Home › Overweight › Missouri › Kansas City
Pag-aaral pangklinika para sa Overweight sa Kansas City, MO
9 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Kansas City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Nagre-recruitPhase 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Nagre-recruitPhase 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Nagre-recruitPhase 3
- Alliance for Multispecialty Research - Kansas City, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
- Research Site, Kansas City
- Research Site, Kansas City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
- Kansas City VA Medical Center, Kansas City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Kansas City
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
Nagre-recruitPhase 1
- MBX Biosciences Investigational Site, Kansas City
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- University Health, Kansas City
- University of Missouri-Kansas City, Kansas City
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL29 pag-aaral
- Orlando, FL27 pag-aaral
- Las Vegas, NV23 pag-aaral
- Miami, FL23 pag-aaral
- Dallas, TX20 pag-aaral
- Atlanta, GA20 pag-aaral
- New York City, NY19 pag-aaral
- Jacksonville, FL19 pag-aaral
- Washington, DC19 pag-aaral
- Austin, TX18 pag-aaral
Iba pang pag-aaral sa Kansas City
- Kanser sa Suso34 pag-aaral
- Non-Small Cell Lung Cancer31 pag-aaral
- Pagkabigo ng Puso25 pag-aaral
- Kanser (lahat ng uri)21 pag-aaral
- Kanser sa Baga19 pag-aaral
- Colorectal Cancer16 pag-aaral
- Metastatic Cancer15 pag-aaral
- Acute Myeloid Leukemia15 pag-aaral
- Kanser sa Prostate14 pag-aaral
- Kanser sa Ovary11 pag-aaral
- Obesity11 pag-aaral
- Type 2 Diabetes11 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.